Search Results - "Klümper, N"

In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score by Saal, J., Bald, T., Hölzel, M., Ritter, M., Brossart, P., Ellinger, J., Klümper, N.

Get full text

1480P Integrating the on-treatment mGPS improves prognostic accuracy of imaging-based staging in patients with non-small-cell lung cancer (NSCLC) treated with immune-checkpoint inhibitors by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Brossart, P., Ellinger, J., Hölzel, M., Klümper, N.

Get full text

On-treatment modified Glasgow prognostic score (mGPS) improves imaging-only prediction of response and outcomes in metastatic renal cell carcinoma by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Ritter, M., Brossart, P., Grünwald, V., Hölzel, M., Ellinger, J., Klümper, N.

Get full text

A0332 - On-treatment modified Glasgow prognostic score (mGPS) improves imaging-only prediction of response and outcomes in metastatic renal cell carcinoma by Saal, J., Bald, T., Eckstein, M., Ralser, D.J., Ritter, M., Brossart, P., Grünwald, V., Hölzel, M., Ellinger, J., Klümper, N.

Get full text

CDCP1 overexpression is associated with a specific immune-infiltrate driving prostate cancer progression by Saponaro, M., D’Ambrosio, M., Schmidt, A., Klümper, N., Hölzel, M., Ritter, M., Alimonti, A., Alajati, A.

Get full text

Membranous NECTIN-4 expression in metastasis versus matched primary tumor more accurately predicts enfortumab vedotin response by Büttner, T., Zschäbitz, S., Bolenz, C., Zengerling, F., Heers, H., Nagy, D., Toma, M., Kristiansen, G., Ellinger, J., Ritter, M., Hartmann, A., Hölzel, M., Eckstein, M., Klümper, N.

Get full text

A0750 - Membranous NECTIN-4 expression in metastasis versus matched primary tumor more accurately predicts enfortumab vedotin response by Büttner, T., Zschäbitz, S., Bolenz, C., Zengerling, F., Heers, H., Nagy, D., Toma, M., Kristiansen, G., Ellinger, J., Ritter, M., Hartmann, A., Hölzel, M., Eckstein, M., Klümper, N.

Get full text

Detection of hypermethylated SHOX2 in circulating cell-free DNA post nephrectomy identifies patients with renal cell carcinoma at highest risk for disease recurrence independent of TNM by Büttner, T., Zarbl, R., Krausewitz, P., Strieth, S., Kristiansen, G., Eckstein, M., Ralser, D., Hölzel, M., Ritter, M., Ellinger, J., Dietrich, D., Klümper, N.

Get full text

Pre-adipocyte-driven NRG1 promotes resistance to FGFR3 inhibition in urothelial carcinoma by Hosni, S., Kilian, V., Klümper, N., Saponaro, M., Ellinger, J., Corvino, D., Gabbia, D., Bald, T., De Martin, S., Hölzel, M., Ritter, M., Eckstein, M., Alajati, A.

Get full text

A1046 - Detection of hypermethylated SHOX2 in circulating cell-free DNA post nephrectomy identifies patients with renal cell carcinoma at highest risk for disease recurrence independent of TNM by Büttner, T., Zarbl, R., Krausewitz, P., Strieth, S., Kristiansen, G., Eckstein, M., Ralser, D., Hölzel, M., Ritter, M., Ellinger, J., Dietrich, D., Klümper, N.

Get full text

A1181 - Pre-adipocyte-driven NRG1 promotes resistance to FGFR3 inhibition in urothelial carcinoma by Hosni, S., Kilian, V., Klümper, N., Saponaro, M., Ellinger, J., Corvino, D., Gabbia, D., Bald, T., De Martin, S., Hölzel, M., Ritter, M., Eckstein, M., Alajati, A.

Get full text

1759P Enfortumab vedotin in metastatic urothelial carcinoma: Retrospective multicentre patient cohort by Darr, C., Zschäbitz, S., Niegisch, G., Roghmann, F., Ivanyi, P., Zengerling, F., Paffenholz, P., Biernath, N., Klee, M., Klümper, N., Tauber, R.L., Hadaschik, B.A., Hilser, T., Grünwald, V.

Get full text

A0539 - Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer by Weiten, R., Niemann, M., Below, E., Friker, L.L., Ralser, D.J., Toma, M., Kristiansen, G., Hahn, O., Zechel, S., Grünwald, V., Bald, T., Siewert, J., Pietsch, T., Ritter, M., Hölzel, M., Eckstein, M., Alajati, A., Krausewitz, P., Klümper, N.

Get full text

Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer by Weiten, R., Niemann, M., Below, E., Friker, L.L., Ralser, D.J., Toma, M., Kristiansen, G., Hahn, O., Zechel, S., Grünwald, V., Bald, T., Siewert, J., Pietsch, T., Ritter, M., Hölzel, M., Eckstein, M., Alajati, A., Krausewitz, P., Klümper, N.

Get full text

Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution by Cox, A., Klümper, N., Stein, J., Sikic, D., Breyer, J., Bolenz, C., Roghmann, F., Erben, P., Wirtz, R.M., Wullich, B., Ritter, M., Hölzel, M., Schwamborn, K., Horn, T., Gschwend, J., Hartmann, A., Weichert, W., Erlmeier, F., Eckstein, M.

Get full text

A1171 - Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution by Cox, A., Klümper, N., Stein, J., Sikic, D., Breyer, J., Bolenz, C., Roghmann, F., Erben, P., Wirtz, R.M., Wullich, B., Ritter, M., Hölzel, M., Schwamborn, K., Horn, T., Gschwend, J., Hartmann, A., Weichert, W., Erlmeier, F., Eckstein, M.

Get full text

N6-Methyladenosine (m6A) readers are dysregulated in renal cell carcinoma by Von Hagen, F., Gundert, L., Strick, A., Klümper, N., Schmidt, D., Kristiansen, G., Tolkach, Y., Toma, M., Ritter, M., Ellinger, J.

Get full text

Deciphering the mechanistic role of PBRM1 loss in inflammatory and morphogenic signalling within the tumour microenvironment of clear cell renal cell carcinoma by Klümper, N., Linxweiler, J., Tran, K.N., Zeuschner, P., Ng, S., Leonardelli, S., Albrecht, J., Rieck, S., Bamarni, A., Lindenberg, T.T., Odermatt, B., Kristiansen, G., Ritter, M., Ellinger, J., Alajati, A., Fleischmann, B.K., Junker, K., Toma, M., Hölzel, M.

Get full text

Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin by Klümper, N., Ralser, D.J., Ellinger, J., Roghmann, F., Breyer, J., Bolenz, C., Zengerling, F., Erben, P., Schwamborn, K., Horn, T., Kristiansen, G., Grünwald, V., Darr, C., Rausch, S., Schlack, K., Zschäbitz, S., Wullich, B., Ritter, M., Hartmann, A., Gschwend, J.E., Weichert, W., Erlmeier, F., Hölzel, M., Eckstein, M.

Get full text

Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition by Erlmeier, F., Klümper, N., Landgraf, L., Strissel, P., Strick, R., Sikic, D., Taubert, H., Wach, S., Geppert, C., Bahlinger, V., Breyer, J., Ritter, M., Bolenz, C., Roghmann, F., Erben, P., Schwamborn, K., Wirtz, R., Horn, T., Wullich, B., Hölzel, M., Hartmann, A., Gschwend, J., Weichert, W., Eckstein, M.

Get full text